Researcher is on a Quest for a Chlamydia Vaccine

Article

Chlamydia is the most frequently reported sexually transmitted disease in the U.S. Its symptoms often are mild or absent, but it can cause serious complications, including pelvic inflammatory disease, ectopic pregnancy and infertility. University of Alabama at Birmingham (UAB) Department of Medicine professor Richard P. Morrison, PhD, has received a five-year, $1.5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) for research on a chlamydia vaccine.

In previous studies, Morrisons has shown that anti-chlamydia antibodies offer excellent protection during genital tract re-infection. In this study, Morrision is further defining and characterizing chlamydia protective antibody-mediated response.

"Sustained control of chlamydial urogenital infections will be achieved only by the development of an efficacious vaccine," Morrison said. "These studies will provide important insight toward achieving that goal."

Source: University of Alabama at Birmingham

 

 

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content